Ophira Ginsburg has joined NYU Langone’s Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
